Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Cerulean Scientific Appoints Tim Hopper As Chief Executive Officer

PRIVATEAug 28, 2024almost 2 years ago

Position

Chief Executive Officer

Company

Cerulean Scientific

Tim Hopper
DurhamBiotechnologyHealth CareMedicalMedical Device

Description

Cerulean Scientific Inc., a leader in medical device innovation, has announced the appointment of Tim Hopper as Chief Executive Officer. Hopper will succeed Lora Allemeier, who is stepping down for personal reasons. The company is developing and commercializing a new category of implantable and indwelling medical devices that resist clogging, obstructions, and biofouling.

Company Information

Company

Cerulean Scientific

Location

Durham, North Carolina, United States

About

Cerulean Scientific is a medical device company developing and commercializing a new category of implantable and indwelling medical devices that resist clogging, obstructions, and biofouling. The company's lead product is the Cerulean Ventricular Shunt, which will help the one million individuals living with hydrocephalus achieve an improved quality of life.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Cerulean Scientific's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.